Dear Mr. Ginsberg,
Thank you for your June 12, 2015, letter to Acting Commissioner Ostroff on behalf of the Global Healthy Living Foundation regarding the labeling of biosimilars. Your letter was forwarded to the Center for Drug Evaluation and Research for response.